Found 13 matching trials
YF476 in Barrett's Esophagus
PHASE2A phase 2, randomised, double-blind, out-patient trial to determine if YF47...
Location
Columbia University, Division of Digestive & Liver Diseases
Effects of YF476 and Rabeprazole on Gastric Function
PHASE1The primary objectives are to find out in healthy subjects if:
* YF476 pre...
Location
Hammersmith Medicines Research
Effect of Repeated Doses of YF476 on Stomach Acidity
PHASE1The objectives of the study were:
1. To show that a single dose of YF476 b...
Location
Hammersmith Medicines Research
Trial of a Gastrin Receptor Antagonist in Barrett's Esophagus
PHASE2The purpose of this study is to determine whether treatment with an experim...
Location
New York Presbyterian Hospital - Columbia
YF476 and Type I Gastric Carcinoids
PHASE2The aim of the study is to find out if the experimental medicine, YF476, ca...
Location
Royal Liverpool University Hospital
YF476 and Type II Gastric Carcinoids
PHASE2This study will evaluate whether treatment with YF476 is safe and effective...
Location
Multiple Locations
Effect of 5, 10 or 25 mg of YF476 Daily for 14 Days on Stomach Acidity in Healthy Volunteers
PHASE1The objective of the study was to assess whether the tolerance to the effec...
Location
Hammersmith Medicines Research
YF476 and Type I Gastric Carcinoids (Norway)
PHASE2The aim of the study is to find out if the experimental medicine, YF476, ca...
Location
Institutt for kreftforskning og molekylaer medisin
Effect of Single Doses of YF476 on Stomach Acidity Compared With Ranitidine and Placebo in Fasted and Fed States
PHASE1The objectives of the study were:
* To compare a single dose of YF476 at 3...
Location
Hammersmith Medicines Research
Effect of Netazepide on Omeprazole-induced Changes in Chromogranin A and Gastrin
PHASE1Hypergastrinaemia induced by proton pump inhibitor (PPI) treatment is repor...
Location
Multiple Locations